Cannaludus

Appearance

How Cannabis Prohibition Took Hold in the U.S. ​

How Cannabis Prohibition Took Hold in the U.S.

Cannabis prohibition in the United States did not happen all at once. It grew out of changing medical regulation, racialized public fear, federal tax law, international drug-control pressure, and a long political campaign that treated cannabis less as a plant and more as a symbol of disorder.

That history still matters. Today, many states allow medical cannabis, adult-use cannabis, or both, while federal law continues to treat most cannabis activity as controlled under the Controlled Substances Act. The result is a legal system full of contradictions: licensed dispensaries may operate openly under state law, while federal restrictions still affect banking, research, taxation, immigration, housing, firearms access, and criminal justice.

Understanding how the country got here helps explain why legalization has been uneven, why cannabis enforcement has fallen hardest on some communities, and why policy change remains complicated even as public attitudes have shifted.

Cannabis before federal prohibition ​

For much of early U.S. history, cannabis was not treated primarily as a criminal issue. Hemp, a variety of the cannabis plant grown for fiber, was cultivated for rope, sailcloth, textiles, and other industrial uses. Cannabis preparations also appeared in nineteenth-century medicine, including tinctures and extracts sold through pharmacies.

The first major federal shift was not a ban. The 1906 Food and Drugs Act focused on misbranding and adulteration in foods and medicines. It required certain ingredients, including cannabis when present in medicines, to be labeled. That was part of a broader Progressive Era push for consumer protection, not cannabis criminalization.

The cultural meaning of cannabis changed in the early twentieth century. State-level restrictions expanded, especially as public anxiety about immigration, urban vice, and drug consumption became tied to sensational media coverage. The term “marihuana,” a spelling used in federal law at the time, became a political tool. Reformers, police officials, and newspapers often framed cannabis as foreign, dangerous, and associated with Mexican immigrants and Black communities. That framing helped move cannabis from a medicine-and-fiber issue into the realm of criminal law.

The 1930s and the federal turn toward prohibition ​

The 1930s brought cannabis into federal drug policy in a more direct way. Harry Anslinger, the first commissioner of the Federal Bureau of Narcotics, became one of the most influential voices in national cannabis prohibition. His office promoted stories linking cannabis to violence, moral decline, and social disorder, claims that were often exaggerated, racially loaded, or unsupported.

Popular propaganda amplified those fears. The 1936 film Reefer Madness is now remembered less as credible public education than as a symbol of prohibition-era panic. Still, it reflected the atmosphere that helped make strict cannabis policy politically possible.

In 1937, Congress passed the Marihuana Tax Act. The law did not simply announce a straightforward ban. Instead, it used registration, taxes, recordkeeping, and penalties to make lawful cannabis activity extremely difficult. In practice, it helped push cannabis out of legitimate medical and commercial channels and gave federal authorities a tool for criminal enforcement.

The American Medical Association objected to aspects of the 1937 law, including its burden on physicians and pharmacists. That detail is important because it complicates the idea that cannabis prohibition was the natural result of medical consensus. Federal prohibition grew through politics, enforcement priorities, and public messaging as much as through health regulation.

From tax law to the Controlled Substances Act ​

The 1937 tax system remained central until the late 1960s. In 1969, the Supreme Court’s decision in Leary v. United States undercut part of the Marihuana Tax Act on Fifth Amendment grounds. Congress soon replaced the old tax-law approach with a broader federal drug-control framework.

In 1970, the Controlled Substances Act classified cannabis in Schedule I. Schedule I is the most restrictive category under federal law and is reserved for substances treated as having a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.

That classification shaped the next several decades. It affected criminal penalties, research access, federal enforcement, and public perception. It also created a sharp divide between federal law and future state-level cannabis reforms.

The Controlled Substances Act did not arrive in a political vacuum. It became part of the larger war on drugs, a set of policies that expanded policing, prosecution, and incarceration for drug offenses. Cannabis was not the only substance targeted, but cannabis enforcement became a major driver of arrests and records that followed people into housing, employment, education, and family life.

Enforcement and unequal harm ​

Cannabis prohibition was not enforced evenly. Communities of color, especially Black communities, experienced disproportionate cannabis enforcement even when consumption rates did not explain the gap. That disparity became one of the central reasons modern legalization debates now include expungement, resentencing, social equity licensing, and community reinvestment.

This history is not only about old laws. Cannabis convictions and arrest records can have long-term consequences even after a state legalizes adult-use cannabis. A person may still face barriers because of an old record, while businesses in newly legal markets may be better positioned to profit from conduct that once led to arrests.

That contradiction is one reason many advocates argue that legalization without repair is incomplete. Removing penalties for future conduct does not automatically address the harm caused by decades of criminalization.

Medical cannabis and the state-level break from federal law ​

The modern legalization era began with medical cannabis. In 1996, California voters approved Proposition 215, the Compassionate Use Act, which protected certain patients and caregivers from state criminal penalties for medical cannabis possession and cultivation with a physician’s recommendation.

California’s law did not change federal law. It did, however, create a model for state-level resistance to federal cannabis prohibition. Other states followed with medical cannabis programs, each with different qualifying conditions, product rules, registration systems, and patient protections.

This state-by-state approach changed the national conversation. Cannabis policy was no longer only a federal criminal issue. It became a patient-access issue, a public-health issue, a regulatory issue, and eventually a tax-and-commerce issue.

Adult-use legalization and the unresolved federal conflict ​

In 2012, Colorado and Washington became the first states to approve adult-use cannabis legalization. Since then, legalization has spread across much of the country, though laws still vary widely by state. Some states allow licensed adult-use sales. Some allow medical cannabis only. Others continue to prohibit most cannabis possession and sales.

The conflict between state and federal law remains one of the defining features of U.S. cannabis policy. A dispensary can be licensed by a state and still operate in an industry affected by federal restrictions. Cannabis businesses may face unusual tax burdens, limited banking access, and barriers to interstate commerce. Consumers may also face consequences in areas governed by federal law or federal funding.

Federal cannabis scheduling has also been in motion. In 2024, the U.S. Department of Justice proposed moving cannabis from Schedule I to Schedule III. As of this update, federal rulemaking has continued, and certain FDA-approved cannabis-related drug products and some state-licensed cannabis products have been addressed through federal scheduling actions. That does not mean cannabis is federally legalized nationwide, and it does not erase the broader state-federal conflict.

What prohibition history teaches today ​

Cannabis prohibition was built through many layers: consumer-protection law, racialized stigma, moral panic, tax enforcement, federal scheduling, and decades of drug-war politics. Legalization is being built in layers too.

That is why cannabis policy can feel inconsistent. A state may legalize possession but limit home cultivation. A medical program may exist while adult-use sales remain prohibited. A person may buy cannabis legally under state law but still face consequences tied to employment, housing, immigration status, or federal benefits.

The main lesson is that legalization is not just the repeal of an old rule. It is the redesign of a system that affected medicine, commerce, policing, research, taxation, and civil rights. The future of cannabis policy will depend not only on whether more states legalize, but on how lawmakers handle expungement, equity, public health, impaired driving, youth prevention, research access, and federal reform.

Key takeaways ​

Cannabis was not always treated as a major criminal issue in the United States. Hemp had industrial uses, and cannabis preparations appeared in medicine before the rise of twentieth-century drug-control laws.

Federal prohibition took shape through racialized fear, propaganda, and the 1937 Marihuana Tax Act, which made lawful cannabis commerce extremely difficult.

The 1970 Controlled Substances Act placed cannabis in Schedule I, setting up decades of federal criminalization and conflict with later state reforms.

Medical cannabis legalization began at the state level with California’s Proposition 215 in 1996, followed by a broader wave of state medical and adult-use laws.

State legalization has changed access and public opinion, but federal law remains a major unresolved issue. Cannabis policy is still evolving, and legal status depends heavily on location and context.

Sources ​